Canton Strategic (CNTN) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

—

Revenue (quarter)

$1.5M

Revenue growth (year over year)

—

Gross profit (trailing twelve months)

—

Gross margin

—

Net income (trailing twelve months)

—

Net income (quarter)

−$19.3M

Net income growth (year over year)

−937.91%

Net margin

—

Return on equity

−43.10%

EPS (trailing twelve months)

$0.18

Book value per share

$5.89

P/E (trailing twelve months)

—

Price to book

0.35

Debt to assets

19.42%

Payout ratio

—

Dividend yield

—

Company profile

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

• How do I buy stock in Canton Strategic (CNTN)?

  CNTN trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.